Avoiding, Treating & Curing Cancer | Dr. Alex Marson

Andrew Huberman and Dr. Alex Marson trace the immune system from first principles (innate vs. adaptive, T cells, B cells, the thymus) into how cancer arises as cells accumulate mutations and divide out of control. They cover real cancer risk factors and how to weigh them, then move into the immunotherapy revolution: checkpoint inhibitors, CAR-T cells, and the story of CRISPR. Marson explains how his lab got CRISPR working in human T cells via electroporation, how engineered cells are now in clinical trials for solid tumors, and how delivery is shifting toward lipid nanoparticles and engineered viruses. The conversation closes on the ethics of germline editing, embryo sequencing, and the future of programmable cells.

• Marson says that when he graduated medical school in 2010 the dogma was 'don't waste time thinking about cancer immunology', a field 'going nowhere', and that the field was simply wrong.
  00:49:58
• Emily Whitehead, treated at age 8 in 2012 as the first pediatric CAR-T patient, was cured of leukemia and is now pre-med at UPenn.
  00:57:13
• Jimmy Carter's metastatic melanoma that had spread to his brain, a presumed death sentence, was essentially cured by checkpoint inhibitors.
  00:53:36
• Marson co-founded Arsenal Biosciences, now in clinical trials for solid tumors including a prostate cancer trial about to enroll patients.
  01:28:15
• Marson takes a hard-line stance: there should be a 'line in the sand' against any heritable (germline) genetic edits passed to the next generation.
  02:01:53
• His lab publicly released a dataset of 22 million human immune cells, each with a different CRISPR gene knocked out, as a functional 'sequel to the genome project'.
  02:16:25
• A billion-plus people have already received lipid nanoparticles, the same delivery tech behind mRNA vaccines is being repurposed to deliver CRISPR.
  01:36:27
• Marson warns that designing offspring via gene selection risks losing human diversity to 'fads' in popular genes, 'a Pinterest culture' for babies.
  02:05:29

• Each T cell carries its own unique, largely randomly generated receptor, one of the few places DNA differs from your inherited germline sequence.
  00:08:18
• T cells lie in wait that could recognize viruses or bacteria that don't even exist yet in nature.
  00:10:53
• Checkpoint inhibitors (PD-1, CTLA-4) work by releasing the natural 'brakes' on T cells so they attack cancer harder.
  00:53:36
• CAR-T against CD19 works partly by luck: it also kills healthy B cells, but the body tolerates losing them.
  01:05:34
• CRISPR originated as a bacterial immune system defending against bacteriophage viruses.
  01:14:51
• Marson's lab gets CRISPR into real human T cells using electroporation, a brief electrical current that opens transient pores in the cell membrane.
  01:25:39
• Researchers have made CAR-T cells inside the body by injecting targeted lipid nanoparticles, without ever removing T cells from the blood.
  01:39:35
• The 2018 Chinese CRISPR-baby experiment deleted the CCR5 gene to try to confer HIV resistance in twin embryos.
  01:59:18
• Yamanaka factors can revert a skin cell to a stem cell, then redirect it into a neuron or pancreatic cell.
  02:19:03
• Most cells that acquire a mutation simply die off via programmed cell death; cancer arises only when mutations give a survival/growth advantage.
  00:35:27